Validation of serum non‐invasive tests of liver fibrosis as prognostic markers of clinical outcomes in people with fatty liver disease in Australia
Several liver fibrosis NITs perform similarly reasonably well in predicting the risk of mortality outcomes in those with FLD but are poorly discriminatory for MALO prediction.
Authors
- Stuart Keith Roberts (ORCID: https://orcid.org/0000-0002-9015-7997)
- Karl Vaz (ORCID: https://orcid.org/0000-0002-6427-6140)
- William Kemp (ORCID: https://orcid.org/0000-0002-0787-7273)
- John Lubel (ORCID: https://orcid.org/0000-0003-0828-0572)
- David S Simmons (ORCID: https://orcid.org/0000-0003-0560-0761)
- Ammar Majeed (ORCID: https://orcid.org/0000-0002-7024-8787)
- Lisa Bourke (ORCID: https://orcid.org/0000-0003-0411-6193)
- Kristen Glenister (ORCID: https://orcid.org/0000-0003-0510-5314)
- Dianna J. Magliano (ORCID: https://orcid.org/0000-0002-6026-5065)
Institutions
- Baker Heart and Diabetes Institute (AU)
- The University of Melbourne (AU)
- Early Manuscripts Electronic Library (US)
- Alfred Health (AU)
- Monash University (AU)
- Western Sydney University (AU)
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2024-10-24
- DOI
- https://doi.org/10.1111/jgh.16774
- Citations
- 4
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- Australian Government
- Department of Health, State Government of Victoria
- Department of Health and Aged Care, Australian Government